{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:22:29Z","timestamp":1780518149708,"version":"3.54.1"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-mobilized bone marrow\u2013derived CD11b+ myeloid cells promote tumor angiogenesis, but how and when these cells acquire proangiogenic properties is not fully elucidated. Here, we show that CD11b+ myelomonocytic cells develop proangiogenic properties during their differentiation from CD34+ hematopoietic progenitors and that placenta growth factor (PlGF) is critical in promoting this education. Cultures of human CD34+ progenitors supplemented with conditioned medium from breast cancer cell lines or PlGF, but not from nontumorigenic breast epithelial lines, generate CD11b+ cells capable of inducing endothelial cell sprouting in vitro and angiogenesis in vivo. An anti\u2013Flt-1 mAb or soluble Flt-1 abolished the generation of proangiogenic activity during differentiation from progenitor cells. Moreover, inhibition of metalloproteinase activity, but not VEGF, during the endothelial sprouting assay blocked sprouting induced by these proangiogenic CD11b+ myelomonocytes. In a mouse model of breast cancer, circulating CD11b+ cells were proangiogenic in the sprouting assays. Silencing of PlGF in tumor cells prevented the generation of proangiogenic activity in circulating CD11b+ cells, inhibited tumor blood flow, and slowed tumor growth. Peripheral blood of breast cancer patients at diagnosis, but not of healthy individuals, contained elevated levels of PlGF and circulating proangiogenic CD11b+ myelomonocytes. Taken together, our results show that cancer cells can program proangiogenic activity in CD11b+ myelomonocytes during differentiation of their progenitor cells in a PlGF-dependent manner. These findings impact breast cancer biology, detection, and treatment. Cancer Res; 71(11); 3781\u201391. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-3684","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T23:12:03Z","timestamp":1303341123000},"page":"3781-3791","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Proangiogenic Factor PlGF Programs CD11b+ Myelomonocytes in Breast Cancer during Differentiation of Their Hematopoietic Progenitors"],"prefix":"10.1158","volume":"71","author":[{"given":"Julien","family":"Laurent","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline Faes-van't","family":"Hull","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Touvrey","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Kuonen","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"},{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girieca","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"},{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Agn\u00e8s","family":"Doucey","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ciarloni","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Alghisi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesta","family":"Fagiani","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Zaman","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Stupp","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masabumi","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Delaloye","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Christofori","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"},{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curzio","family":"Ruegg","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"},{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"},{"name":"Authors' Affiliations:\u20081Division of Experimental Oncology (DEO), 2The Breast Center, Centre Pluridisciplinaire d'Oncologie (CePO), and 3The Breast Center, Department of Obstetrics and Gynecology, 4Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Faculty of Biology and Medicine; 5National Center for Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research, Ecole Polytechnique F\u00e9derale de Lausanne (ISREC-EPFL-SV), Lausanne; 6Pathology, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg; 7Institute of Biochemistry and Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; and 8Tokyo Medical and Dental University, Department of Molecular Oncology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"2022061706310912600_bib1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"2022061706310912600_bib2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"2022061706310912600_bib3","first-page":"159","article-title":"Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis","volume":"1766","author":"De Palma","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"2022061706310912600_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2022061706310912600_bib5","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1073\/pnas.0712185105","article-title":"Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression","volume":"105","author":"Shojaei","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706310912600_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","article-title":"VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells","volume":"124","author":"Grunewald","year":"2006","journal-title":"Cell"},{"key":"2022061706310912600_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm1400","article-title":"Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4 +hemangiocytes","volume":"12","author":"Jin","year":"2006","journal-title":"Nat Med"},{"key":"2022061706310912600_bib8","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"2022061706310912600_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nature06348","article-title":"Bv8 regulates myeloid-cell-dependent tumour angiogenesis","volume":"450","author":"Shojaei","year":"2007","journal-title":"Nature"},{"key":"2022061706310912600_bib10","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1182\/blood-2006-10-053504","article-title":"Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer","volume":"109","author":"Venneri","year":"2007","journal-title":"Blood"},{"key":"2022061706310912600_bib11","first-page":"2062","article-title":"Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice","volume":"118","author":"Zacchigna","year":"2008","journal-title":"J Clin Invest"},{"key":"2022061706310912600_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccr.2008.02.016","article-title":"A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization","volume":"13","author":"Seandel","year":"2008","journal-title":"Cancer Cell"},{"key":"2022061706310912600_bib13","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1073\/pnas.0600065103","article-title":"Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism","volume":"103","author":"Ayyanan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706310912600_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/bcr77","article-title":"Nontransgenic models of breast cancer","volume":"2","author":"Heppner","year":"2000","journal-title":"Breast Cancer Res"},{"key":"2022061706310912600_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/nm0901-1041","article-title":"NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42\/Rac-dependent endothelial-cell spreading, migration and angiogenesis","volume":"7","author":"Dormond","year":"2001","journal-title":"Nat Med"},{"key":"2022061706310912600_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1365-2141.2002.03873.x","article-title":"Long-term ex vivo expansion of human fetal liver primitive haematopoietic progenitor cells in stroma-free cultures","volume":"119","author":"Peters","year":"2002","journal-title":"Br J Haematol"},{"key":"2022061706310912600_bib17","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1242\/jcs.112.19.3249","article-title":"Tensional forces in fibrillar extracellular matrices control directional capillary sprouting","volume":"112","author":"Korff","year":"1999","journal-title":"J Cell Sci"},{"key":"2022061706310912600_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/cyto.a.20969","article-title":"Fc block treatment, dead cells exclusion, and cell aggregates discrimination concur to prevent phenotypical artifacts in the analysis of subpopulations of tumor-infiltrating CD11b(+) myelomonocytic cells","volume":"77","author":"Kuonen","year":"2010","journal-title":"Cytometry A"},{"key":"2022061706310912600_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnci\/52.2.413","article-title":"Tumor growth and neovascularization: an experimental model using the rabbit cornea","volume":"52","author":"Gimbrone","year":"1974","journal-title":"J Natl Cancer Inst"},{"key":"2022061706310912600_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","article-title":"Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans","volume":"97","author":"Sawano","year":"2001","journal-title":"Blood"},{"key":"2022061706310912600_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nmeth913","article-title":"Enhancing and confirming the specificity of RNAi experiments","volume":"3","author":"Cullen","year":"2006","journal-title":"Nat Methods"},{"key":"2022061706310912600_bib22","first-page":"411","article-title":"Anti-tumor angiogenic effect of a matrix metalloproteinase inhibitor MMI270","volume":"23","author":"Nakamura","year":"2003","journal-title":"Anticancer Res"},{"key":"2022061706310912600_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","article-title":"Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors","volume":"8","author":"De Palma","year":"2005","journal-title":"Cancer Cell"},{"key":"2022061706310912600_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2008.09.004","article-title":"Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis","volume":"14","author":"De Palma","year":"2008","journal-title":"Cancer Cell"},{"key":"2022061706310912600_bib25","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ncponc1150","article-title":"Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?","volume":"5","author":"Sessa","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"2022061706310912600_bib26","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1158\/0008-5472.CAN-06-2407","article-title":"Preparing the \u201csoil\u201d: the premetastatic niche","volume":"66","author":"Kaplan","year":"2006","journal-title":"Cancer Res"},{"key":"2022061706310912600_bib27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nature05760","article-title":"Mediators of vascular remodelling co-opted for sequential steps in lung metastasis","volume":"446","author":"Gupta","year":"2007","journal-title":"Nature"},{"key":"2022061706310912600_bib28","first-page":"537","article-title":"PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance","volume":"23","author":"Escudero-Esparza","year":"2010","journal-title":"Oncol Rep"},{"key":"2022061706310912600_bib29","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.ejca.2005.07.022","article-title":"Placenta growth factor is over-expressed and has prognostic value in human breast cancer","volume":"41","author":"Parr","year":"2005","journal-title":"Eur J Cancer"},{"key":"2022061706310912600_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.athoracsur.2009.04.038","article-title":"Placenta growth factor expression has prognostic value in malignant pleural mesothelioma","volume":"88","author":"Pompeo","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2022061706310912600_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hed.21335","article-title":"Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer","volume":"32","author":"Cheng","year":"2010","journal-title":"Head Neck"},{"key":"2022061706310912600_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-3-68","article-title":"Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance","volume":"3","author":"Zhang","year":"2005","journal-title":"World J Surg Oncol"},{"key":"2022061706310912600_bib33","first-page":"239","article-title":"PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance","volume":"6","author":"Escudero-Esparza","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"key":"2022061706310912600_bib34","first-page":"3767","article-title":"Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia","volume":"23","author":"Matsumoto","year":"2003","journal-title":"Anticancer Res"},{"key":"2022061706310912600_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1006198422718","article-title":"Placenta growth factor (PlGF) mRNA expression in brain tumors","volume":"40","author":"Nomura","year":"1998","journal-title":"J Neurooncol"},{"key":"2022061706310912600_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.canlet.2006.10.005","article-title":"Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma","volume":"250","author":"Ho","year":"2007","journal-title":"Cancer Lett"},{"key":"2022061706310912600_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2004.05.020","article-title":"The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer","volume":"213","author":"Chen","year":"2004","journal-title":"Cancer Lett"},{"key":"2022061706310912600_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"key":"2022061706310912600_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"2022061706310912600_bib40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","article-title":"Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease","volume":"141","author":"Van de Veire","year":"2010","journal-title":"Cell"},{"key":"2022061706310912600_bib41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.0000057997.77714.72","article-title":"VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism","volume":"92","author":"Pipp","year":"2003","journal-title":"Circ Res"},{"key":"2022061706310912600_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cell.2010.01.033","article-title":"PlGF blockade does not inhibit angiogenesis during primary tumor growth","volume":"141","author":"Bais","year":"2010","journal-title":"Cell"},{"key":"2022061706310912600_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"2022061706310912600_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"key":"2022061706310912600_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1535-6108(02)00153-8","article-title":"MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis","volume":"2","author":"Hiratsuka","year":"2002","journal-title":"Cancer Cell"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/11\/3781\/2869492\/3781.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/11\/3781\/2869492\/3781.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T15:14:54Z","timestamp":1655478894000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/71\/11\/3781\/657535\/Proangiogenic-Factor-PlGF-Programs-CD11b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,5,31]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-3684","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22395404","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395398.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395401.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395407","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395398","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395395","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395401","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6504293.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395410","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6504293","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395407.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395410.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395395.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395404.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}